AG˹ٷ

STOCK TITAN

Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Tilray Brands (Nasdaq: TLRY) has submitted an application for an extension to regain compliance with Nasdaq's minimum share price listing requirements. The company is considering several options, including a potential stockholder-approved Reverse Stock Split to maintain its Nasdaq listing.

CEO Irwin Simon noted that Tilray's stock has seen recent appreciation following President Trump's cannabis rescheduling review, which he believes reflects investor confidence in the company's global platform. The company aims to leverage its position in cannabis, beverage, and wellness industries while giving the market additional time to recognize its business strategy value.

Tilray Brands (Nasdaq: TLRY) ha presentato una richiesta di estensione per tornare in conformità con i requisiti minimi di prezzo per azione imposti da Nasdaq. L'azienda sta valutando diverse opzioni, inclusa una possibile riduzione del numero di azioni tramite raggruppamento azionario inverso approvato dagli azionisti per mantenere la sua quotazione su Nasdaq.

Il CEO Irwin Simon ha osservato che il titolo di Tilray ha registrato una recente rivalutazione dopo la revisione sulla riclassificazione della cannabis avviata dal presidente Trump, evento che secondo lui riflette la fiducia degli investitori nella piattaforma globale dell'azienda. La società intende sfruttare la sua posizione nei settori della cannabis, delle bevande e del benessere, dando al mercato tempo aggiuntivo per riconoscere il valore della sua strategia aziendale.

Tilray Brands (Nasdaq: TLRY) ha presentado una solicitud de prórroga para recuperar el cumplimiento con los requisitos mínimos de precio por acción de Nasdaq. La compañía está considerando varias opciones, incluida una posible consolidación inversa de acciones aprobada por los accionistas para mantener su cotización en Nasdaq.

El director ejecutivo Irwin Simon señaló que la acción de Tilray experimentó una apreciación reciente tras la revisión de la reclasificación del cannabis por parte del presidente Trump, lo que, en su opinión, refleja la confianza de los inversores en la plataforma global de la empresa. La compañía pretende aprovechar su posición en los sectores de la cannabis, las bebidas y el bienestar, y dar al mercado tiempo adicional para reconocer el valor de su estrategia empresarial.

Tilray Brands (Nasdaq: TLRY)� 나스닥의 최소 주가 상장 요건� 회복하기 위해 준� 기간 연장 신청서를 제출했습니다. 회사� 상장� 유지하기 위해 주주 승인� 따른 가능한 역병�(Reverse Stock Split)� 포함� 여러 옵션� 검토하� 있습니다.

CEO 어윈 사이먼은 트럼� 대통령� 대마초 재분� 검� 이후 틸레� 주가가 최근 상승했다� 언급하며, 이는 회사� 글로벌 플랫폼에 대� 투자� 신뢰� 반영한다� 보았습니�. 회사� 대마초, 음료 � 웰니� 산업에서� 입지� 활용하는 한편 시장� 회사� 사업 전략 가치를 인식� � 있도� 추가 시간� 제공하려� 합니�.

Tilray Brands (Nasdaq: TLRY) a déposé une demande de prolongation afin de retrouver la conformité aux exigences minimales de prix par action du Nasdaq. La société envisage plusieurs options, y compris un éventuel regroupement d'actions inversé approuvé par les actionnaires pour conserver sa cotation au Nasdaq.

Le PDG Irwin Simon a noté que le titre Tilray s'était apprécié récemment après l'examen par le président Trump d'une reclassification du cannabis, ce qui, selon lui, reflète la confiance des investisseurs dans la plateforme mondiale de la société. L'entreprise vise à tirer parti de sa position dans les secteurs du cannabis, des boissons et du bien‑être, tout en donnant au marché du temps supplémentaire pour reconnaître la valeur de sa stratégie commerciale.

Tilray Brands (Nasdaq: TLRY) hat einen Antrag auf Verlängerung gestellt, um die Einhaltung der Mindestkursanforderungen von Nasdaq wiederherzustellen. Das Unternehmen prüft mehrere Optionen, darunter eine mögliche von den Aktionären genehmigte Aktienzusammenlegung (Reverse Stock Split), um die Notierung bei Nasdaq aufrechtzuerhalten.

CEO Irwin Simon bemerkte, dass die Tilray-Aktie nach der Überprüfung einer Umklassifizierung von Cannabis durch Präsident Trump zuletzt an Wert gewonnen habe, was seiner Ansicht nach das Vertrauen der Investoren in die globale Plattform des Unternehmens widerspiegelt. Das Unternehmen will seine Position in den Bereichen Cannabis, Getränke und Wellness nutzen und dem Markt zusätzliche Zeit geben, den Wert seiner Geschäftsstrategie anzuerkennen.

Positive
  • None.
Negative
  • Risk of potential delisting from Nasdaq due to share price non-compliance
  • Possible reverse stock split which could be viewed negatively by market
  • Regulatory uncertainty affecting business operations

NEW YORK and LEAMINGTON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray� or the “Company�) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that the Company has submitted an application requesting an extension to regain compliance with Nasdaq’s listing standards regarding its price per share. The Company is evaluating several options including, but not limited to, a stockholder-approved Reverse Stock Split to address capital structure and maintain adherence to Nasdaq’s continued listing requirements.

Irwin Simon, Chief Executive Officer, Tilray Brands, stated, “Tilray’s trading levels have appreciated in recent weeks following President Trump’s review of cannabis rescheduling. We believe this market reaction reflects investors� confidence in Tilray’s diversified global platform and our ability to capitalize on a more favorable regulatory environment. Tilray is a leader in cannabis, beverage, and wellness, and our growth potential extends beyond any single regulatory change. We are pleased to see investors more accurately recognizing the intrinsic value of our differentiated business portfolio. Tilray has multiple options to meet Nasdaq’s requirements, and with this extension request, we are giving the market additional time to demonstrate its confidence in our long-term strategy. We are building the future of consumer goods at Tilray, creating value for our customers, patients, and shareholders through a commitment to innovation at global scale.�

About Tilray Brands

Tilray Brands, Inc. (“Tilray�) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we are elevating lives through moments of connection, visit and follow @Tilray on all social platforms.

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements�) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor� created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,� “future,� “should,� “could,� “enable,� “potential,� “contemplate,� “believe,� “anticipate,� “estimate,� “plan,� “expect,� “intend,� “may,� “project,� “will,� “would� and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things the timing, ratio and completion of the Reverse Stock Split and expected strategic benefits and cost savings. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

Contacts:
Investor Relations

Media


FAQ

Why is Tilray (TLRY) requesting a Nasdaq listing extension?

Tilray is requesting an extension to regain compliance with Nasdaq's minimum share price requirements, giving the market more time to reflect the company's value while considering options including a potential reverse stock split.

What options is Tilray considering to maintain its Nasdaq listing?

Tilray is evaluating several options, with the primary consideration being a stockholder-approved Reverse Stock Split to address its capital structure and maintain Nasdaq listing compliance.

How has cannabis rescheduling affected Tilray's stock?

According to CEO Irwin Simon, Tilray's stock has appreciated in recent weeks following President Trump's cannabis rescheduling review, reflecting increased investor confidence in the company's global platform.

What are Tilray's main business segments in 2025?

Tilray operates as a global lifestyle consumer packaged goods company focused on three main segments: cannabis, beverage, and wellness industries.

What happens if Tilray fails to meet Nasdaq listing requirements?

If Tilray fails to meet Nasdaq's minimum share price requirements and cannot implement successful remediation measures, the company could face delisting from the Nasdaq exchange.
TILRAY BRANDS INC

NASDAQ:TLRY

TLRY Rankings

TLRY Latest News

TLRY Latest SEC Filings

TLRY Stock Data

1.01B
1.09B
0.77%
9.06%
16.94%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Canada
NEW YORK